Contact
Please use this form to send email to PR contact of this press release:
MediciNova Announces Positive Top-Line Results from the Clinical Trial of MN-166 (ibudilast) in ALS
TO:
Please use this form to send email to PR contact of this press release:
MediciNova Announces Positive Top-Line Results from the Clinical Trial of MN-166 (ibudilast) in ALS
TO: